Ex-Merlin BioMed exec starts healthcare strat

Wed Jan 20, 2010



U.S. healthcare spending has increased from 4.5% of the GDP in 1950 to 16% in 2008, and yet infant mortality and life expectancy in the U.S. is still behind Western Europe, Japan, Australia and Canada.


Stuart Weisbrod, founder of the now-closed Merlin BioMed Group, recently formed Iguana Healthcare Partners and launched a long/short fund on Jan. 1.


Before founding Greenwich, Conn.-based Iguana in the fall of 2009, Weisbrod ran Merlin BioMed, a long/short healthcare-oriented hedge fund he founded in 1998 and closed in December 2007. He served as chief investment officer and the firm’s funds achieved a net annualized return of more than...

ISSN: 2151-1845 / CDC10004H

Register

By registering you will receive

  • A monthly newsletter on your specified areas of interest
  • A fortnightly update on the sector

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates


Popular Searches on HFI